AVI BioPharma 2008 News Archive

December

• AVI BioPharma Announces FDA Clearance of IND Applications for Clinical Trials of RNA Therapeutic Agents for Treatment of Ebola and Marburg Viruses December 23, 2008, PORTLAND, Ore.
• AVI BioPharma Strengthens its Patent Position in RNA Therapeutics December 23, 2008, PORTLAND, Ore.
• AVI BioPharma to Present at FDA Public Hearing Regarding Priority Review Vouchers December 11, 2008, PORTLAND, Ore.
• AVI BioPharma Files IND for Clinical Trial of Marburg Virus Treatment December 3, 2008, PORTLAND, Ore.
• AVI BioPharma Files IND for Clinical Trial of Ebola Virus Treatment December 3, 2008, PORTLAND, Ore.

November

• AVI BioPharma Strengthens Patent Position in Exon Skipping November 24, 2008, PORTLAND, Ore.
• AVI BioPharma Announces Third Quarter 2008 Financial Results November 10, 2008, PORTLAND, Ore.
• AVI BioPharma Announces Initiation of Clinical Trial of Next Generation Drug Eluting Stent by Partner Global Therapeutics November 10, 2008, PORTLAND, Ore.
• AVI BioPharma Announces Third Quarter 2008 Financial Results Conference Call November 4, 2008, PORTLAND, Ore.
• AVI BioPharma to Present at Rodman & Renshaw’s Annual Global Investment Conference Nov. 11, 2008 November 4, 2008, PORTLAND, Ore.

October

• AVI BioPharma to Co-Host Exon Skipping Conference for Duchenne Muscular Dystrophy October 14, 2008, PORTLAND, Ore.
• AVI BioPharma’s Drug for Duchenne Muscular Dystrophy Recommended for Orphan Drug Status in EU and Receiving Provisional GTAC Approval for Clinical Trial in UK October 14, 2008, PORTLAND, Ore.
• AVI BioPharma to Present at the JMP and Maxim Healthcare Conferences October 1, 2008, PORTLAND, Ore.

September

• AVI BioPharma to Present at the UBS Global Life Sciences Conference September 22, 2008, PORTLAND, Ore.
• AVI BioPharma - Investor and Analyst Breakfast Recording and Presentations September 11, 2008, PORTLAND, Ore.
• AVI BioPharma — Investor and Analyst Breakfast Schedule September 8, 2008, PORTLAND, Ore.
• AVI BioPharma to Host Analyst & Investor Breakfast Meeting September 8, 2008, PORTLAND, Ore.

August

• AVI BioPharma Announces Approval to Conduct Systemic Trial for Duchenne Muscular Dystrophy and Second Quarter 2008 Financial Results August 11, 2008, PORTLAND, Ore.
• AVI BioPharma Announces Second Quarter 2008 Financial Results Conference Call August 7, 2008, PORTLAND, Ore.
• AVI BioPharma to Present at BMO Healthcare Conference August 4, 2008, PORTLAND, Ore.

July

• AVI BioPharma Appoints New Senior Vice President and Chief Financial Officer July 28, 2008, PORTLAND, Ore.

June

• AVI BioPharma Announces Partner’s Advance in Cardiovascular Program June 16, 2008, PORTLAND, Ore.
• AVI BioPharma Publishes Preclinical Data in Muscular Dystrophy Research June 12, 2008, PORTLAND, Ore.
• AVI BioPharma Provides Update on New Business Plan: Increased Pipeline Focus, Skill Base and Strategy June 10, 2008, PORTLAND, Ore.
• AVI BioPharma to Present at the 6th Annual Biodefense Vaccines and Therapeutics Meeting June 9, 2008, PORTLAND, Ore.

May

• AVI BioPharma to Present at the American Society of Gene Therapy Meeting May 29, 2008, PORTLAND, Ore.
• AVI BioPharma to Present at TIDES Meeting May 20, 2008, PORTLAND, Ore.
• AVI BioPharma Incorporated First Quarter 2008 Results Conference Call Transcript May 14, 2008, PORTLAND, Ore.
• AVI BioPharma Announces Significant Advance in the Potential Treatment of Ebola and Marburg Virus Infections May 13, 2008, PORTLAND, Ore.
• AVI BioPharma Announces First Quarter 2008 Financial Results May 12, 2008, PORTLAND, Ore.
• AVI BioPharma Publishes Preclinical Data Reducing Inflammation in Hepatitis and Arthritis May 12, 2008, PORTLAND, Ore.
• AVI BioPharma Announces First Quarter 2008 Financial Results Conference Call May 8, 2008, PORTLAND, Ore.

April

• AVI BioPharma Announces Dr. Ryszard Kole as Senior Vice President of Discovery Research April 16, 2008, PORTLAND, Ore.

March

• AVI BioPharma Incorporated Fourth Quarter 2007 Results Conference Call Transcript March 30, 2008, PORTLAND, Ore.
• AVI BioPharma Announces Close of Ercole Biotech Acquisition March 24, 2008, PORTLAND, Ore.
• AVI BioPharma Announces Acquisition of Ercole Biotech March 13, 2008, PORTLAND, Ore.
• AVI BioPharma Announces 2007 Fourth Quarter and Full Year Financial Results March 12, 2008, PORTLAND, Ore.
• AVI BioPharma Announces 2007 Fourth Quarter and Year End Financial Results Conference Call March 5, 2008, PORTLAND, Ore.

February

• AVI BioPharma Names Dr. Leslie Hudson as Chief Executive Officer February 11, 2008, PORTLAND, Ore.

News Archives

• 2008
• 2007
• 2006
• 2005
• 2004
• 2003
• 2002

Return to Latest News

---

Subscribe to the AVI RSS Newsfeed